Quantum computing is the earliest-stage, most speculative theme covered in this whole conversation

[admin]

Quantum computing is the earliest-stage, most speculative theme covered in this whole conversation — the revenue base is tiny by comparison to everything else you've asked about, but the growth rates and long-term value projections are among the most extreme.BackgroundQuantum computing uses quantum-mechanical effects (qubits, superposition, entanglement) to perform certain calculations — optimization, simulation, cryptography, machine learning — far faster than classical computers in theory, though the technology remains in an early, unproven commercial stage known as the "NISQ" (Noisy Intermediate-Scale Quantum) era. Quantum computers have achieved processing capabilities exceeding 433 qubits in operational systems, a significant leap from the 53-qubit benchmark in 2019 — genuine hardware progress, but still short of the fault-tolerant, error-corrected systems most experts see as necessary for broad commercial advantage.This is by far the widest estimate dispersion of any sector in this entire conversation. Depending on source and scope, the 2026 global quantum computing market ranges from as low as $0.48 billion to as high as $16.4 billion — a more than 30x spread. The more consistent, higher-confidence figures cluster in the $1.8-5.6 billion range for 2026, with growth rates almost uniformly in the 20-40% CAGR range regardless of which absolute figure is used. Industry-body data (rather than commercial market-research estimates) puts it in useful context: the global quantum market reached $1.9 billion in 2025 to include quantum computing at $1.4 billion and quantum sensing at $470 million, and the quantum industry crossed $1 billion in total revenue during 2025, with projections to reach $4.4 billion by 2028.Why people invest — the core reasons

• Long-term economic value estimates are enormous relative to current market size. McKinsey's 2026 Quantum Technology Monitor revised the estimated economic value of quantum technologies to between $1.3 trillion and $2.7 trillion by 2035 — meaning the addressable opportunity is estimated at hundreds of times today's actual revenue, similar in character (though earlier-stage) to the AI market's growth story.
• Public and private capital commitment is accelerating sharply. Public funding commitments for quantum research reached an estimated $56.7 billion total, while private venture capital investment in the quantum industry was $4.9 billion in 2025, more than doubling the prior year's record high — a clear signal of institutional confidence outpacing current commercial revenue.
• Government national strategies are providing durable, multi-year backing. The UK government announced a £2 billion four-year quantum investment program in March 2026, projecting contributions of up to £200 billion to the UK economy, and more than 30 countries have launched national quantum initiatives — a similar pattern of state-backed strategic investment to what's driving semiconductors and clean energy.
• A first credible pure-play public company has emerged. IonQ became the first publicly traded quantum computing firm to exceed $100 million in annual GAAP revenue, reporting 202% year-on-year growth and ending 2025 with $3.3 billion in cash and investments — an early proof point that commercial quantum revenue, while small, is real and growing fast.
• Hyperscalers are embedding quantum into broader compute strategy. IBM and AMD announced a partnership to develop next-generation computing architectures combining quantum computing and high-performance computing, referred to as quantum-centric supercomputing, and IBM has booked $1 billion in cumulative quantum business since 2017 — showing incumbents are integrating quantum as a complement to classical/AI compute rather than a separate bet.
• BFSI and healthcare offer the clearest near-term commercial use cases. The BFSI segment accounted for the largest market share, contributing approximately 25% of total revenue, given the industry's need for risk-management, portfolio-optimization, and fraud-detection capabilities, while the healthcare segment is expected to witness the largest CAGR through 2035, driven by quantum-enabled drug discovery — both directly relevant to your existing fintech and biotech/genomics research.
• Cloud-based access is lowering the barrier to commercial adoption. Quantum-computing-as-a-service accelerates market growth by making advanced quantum resources accessible on demand, without requiring costly hardware investments, with leading firms like IBM, Microsoft, and Amazon Web Services expanding cloud-based quantum service offerings — a similar democratization pattern to how cloud computing itself scaled adoption years ago.
• M&A activity signals early-stage consolidation and validation. IonQ acquired Capella Space, Lightsynq, Oxford Ionics, Qubitekk, and Vector Atomic in 2025 while securing a majority stake in ID Quantique, with its proposed acquisition of SkyWater Technology expected to close in 2026 — aggressive consolidation by a leading pure-play suggests the sector is entering a scaling phase, not just a research phase.

The gainsThe QED-C industry report found more than half of quantum companies anticipate at least an 11% increase in revenue from 2025 to 2026, with 37% of companies surveyed projecting more than 25% increase in revenue — genuine bottom-up commercial confidence, not just top-down forecasting. At the company level, IonQ projected $225-245 million in revenue for 2026, continuing its steep growth trajectory, while D-Wave reported 2025 revenue of $24.6 million — illustrating the wide gap even among the most prominent public pure-plays. Regionally, the picture is somewhat split by source: some estimates show North America dominating with a 43.88% market share in 2025, while others show Europe leading with 33.4%, reflecting a genuinely multi-polar early-stage industry without one dominant regional hub yet, similar in character to the early AI/genomics landscape.Risks

• By far the widest and least reliable market-sizing data in this entire conversation. With 2026 estimates ranging from under $500 million to over $16 billion — more than a 30x spread — this is a market where "size of the opportunity" is genuinely not a settled fact, more so than any other sector covered. Any comparative figure absolutely requires picking one source and stating its methodology clearly.
• Still fundamentally a pre-commercial, research-stage technology for most use cases. The industry is now at an inflection point, where within the next few years, the technology must demonstrate scalability, realize use-cases, and secure early adopters to return value on the billions already invested — an explicit acknowledgment from industry analysts that commercial proof is still pending, not yet delivered.
• Extremely high technical and execution risk. Named barriers include high development costs, shortage of skilled quantum professionals, hardware stability challenges, scalability limitations, and technical complexities associated with large-scale commercialization — a materially higher technical-risk profile than any software or even semiconductor theme covered in this conversation.
• Valuations are rising faster than technical proof points, a classic bubble warning sign. McKinsey's own analysis notes that the cost of investing in new or scaling quantum start-ups is rising, with valuations climbing while talent and progress concentrate among a few highly capitalized leaders — an explicit, named concern from a credible source, not speculation.
• Talent shortage is acute even relative to other tech sectors. The global dedicated quantum workforce approached only 16,500 professionals in 2025 — a genuinely small talent pool globally, smaller than most single mid-cap tech companies' headcount, constraining how fast even well-funded firms can execute.
• Revenue remains tiny relative to capital invested, an efficiency concern. Total industry revenue crossed just $1 billion in 2025 against tens of billions in public funding and billions in private VC — a much wider gap between capital deployed and revenue generated than in AI, cybersecurity, or any other sector in this conversation, meaning returns depend heavily on long-dated future potential rather than current fundamentals.
• Limited investable public universe with high single-stock concentration risk. Most quantum activity remains private, government-funded, or embedded within diversified tech giants (IBM, Google, Microsoft, Amazon) rather than accessible as pure-plays — IonQ and D-Wave represent much of the direct public exposure, meaning a portfolio approach here carries significant single-company risk rather than the diversified access points available in more mature sectors like cybersecurity or networking.
• Technology-path uncertainty adds a layer of risk not present in more settled sectors. Multiple competing qubit technologies (superconducting, trapped-ion, photonic, topological, quantum annealing) are still vying for dominance, with no clear technical winner yet — comparable to betting on an unsettled architecture race, a risk category absent from mature sectors like networking hardware or pharma.

Not financial advice — just the landscape, and worth flagging this is genuinely the earliest-stage, highest-uncertainty theme in your whole technology investment universe so far.